Efficacy and Safety of HRS9531 Injection in Type 2 Diabetes Subjects

NCT05966272 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

199

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: HRS9531 injection
DRUG: HRS9531 injection Placebo

Sponsor

Fujian Shengdi Pharmaceutical Co., Ltd.